ConsortiEX Blog

ConsortiEX | ASHP Midyear 2023

FDA Issues New Guidance on Suspect and Illegitimate Product

The FDA recently issued guidance on the definition of Suspect and Illegitimate Products, set forth in the Federal Food Drug and Cosmetic Act1. This guidance aims to assist trading partners in putting systems in place to identify and handle suspect and illegitimate products, meeting Drug Supply Chain Security Act[...]

DSCSA Debunked; Myths vs. Reality

What’s Next for DSCSA Dispenser Requirements?

The Drug Supply Chain Security Act (DSCSA) is Title II of the Drug Quality and Security Act (DQSA) and is designed to protect consumers from potentially harmful drugs. New requirements roll out on November 27th of each year. Each new requirement progresses toward building an electronic, interoperable system to[...]

What’s the 2019 DSCSA Requirement and Why Was it Delayed?

The Drug Supply Chain Security Act (DSCSA) is Title II of the Drug Quality and Security Act (DQSA), which was enacted to enhance FDA’s ability to protect consumers from exposure to potentially harmful drugs. The act outlines steps to build an electronic, interoperable system to identify and trace certain prescription[...]

ConsortiEX Will be Attending ASHP Midyear!

The ConsortiEX family is currently ramping up for the 2019 ASHP Midyear Clinical Meeting, but we want to take a moment to thank all of our customers for their continued partnership on our journey to improve patient outcomes, and in securing the pharmaceutical supply chain. We remain committed to providing health care[...]

ConsortiEX ASHP 2019 Summer Meetings and Exhibition Recap

We would like to thank all attendees of the ASHP Summer Meetings who stopped by to see us. Having the opportunity to discuss our compliance solutions, in-person, is one that we do not take for granted.

ConsortiEX is attending the 2019 ASHP Summer Meetings

ConsortiEX will be shipping up to Boston for this year’s ASHP Summer Meeting. We encourage you to stop at Booth 201 for an in-person look at how you can use our intuitive DQSA Compliance solutions to enhance patient safety, ensure quality control and simplify your compliance needs.

6 Best Practices to Help Achieve DSCSA Compliance

Many hospitals struggle to achieve optimal compliance with the Drug Supply Chain Security Act (DSCSA). The challenge to comply seems to come from an incomplete or inaccurate understanding of the regulations, which is understandable given the Act’s complexity. DSCSA was put in place to protect consumers from harmful[...]

DSCSA Compliance as a Service: T3 Verification

ConsortiEX is proud to announce T3 verification, the newest feature to be added to our DSCSA Compliance as a Service (CaaS) module. The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy.

1 2

Topics

See all